series-a
Stage
3
Investors
About
CardioSignal develops a CE-marked Class IIb medical device software that uses gyrocardiography to enable smartphone-based, non-invasive detection of atrial fibrillation within one minute for self-monitoring, clinical use, and population health programs.
Explore CardioSignal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.